| Literature DB >> 30769830 |
Pawel Pomastowski1, Boguslaw Buszewski2,3.
Abstract
In recent years, matrix-assisted laser desorption/Entities:
Keywords: MALDI; NALDI; bioanalytics; matrix-assisted laser desorption/ionization; nanoparticles; nanostructures-assisted laser desorption/ionization
Year: 2019 PMID: 30769830 PMCID: PMC6410089 DOI: 10.3390/nano9020260
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Ionization and desorption processes in matrix-assisted laser desorption/ionization (MALDI).
Short-review of matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry (MALDI-TOF MS) methods used for the identification and analysis of different proteins.
| Protein | Molecular Mass [kDa] | Sequence Coverage (SC) | Post-Translation Modifications | Reference |
|---|---|---|---|---|
| Connexin26 | - | 71.3% | acetylation, hydroxylation, γ-carboxyglutamation, methylation, phosphorylation | [ |
| Carbonic anhydrase IX (CA IX) | 44.48 | - | - | [ |
| αs1-CN | 23.61 | 75% | phosphorylation | [ |
| 25.0 | 54% | [ | ||
| β-CN | 23.99 | 37–49% | [ | |
| 29.0 | 51% | [ | ||
| κ-CN | 19.0 | 33–35% | phosphorylation | [ |
| - | - | O-glycosylation | [ | |
| α-lactalbumin | 14.199 | - | - | [ |
| - | - | N-glycosylation | [ | |
| β-lactoglobulin | 18.397 | - | - | [ |
| - | - | N-glycosylation | [ | |
| Lactoferrin | 77.167-81.189 | 19–25% | Glycosylation | [ |
| 84.011 | - | [ | ||
| Bovine serum albumin (BSA) | 62.0 | 35.7–43.9% | - | [ |
| Transferrin | - | 41.8–56.4% | - | [ |
| - | - | N-glycosylation | [ | |
| 79.562 | - | O- and N-glycosylation | [ |
Figure 2Mechanism of ionization in nanostructure-assisted laser desorption/ionization (NALDI).
Figure 3Principle of surface-enhanced laser desorption/ionization approach.
Review of application of metal and metal oxide nanoparticles for laser desorption/ionization (LDI) detection.
| Matrix | Analytes, Sample | Synthesis | Analytes Deposition | LOD | Reference |
|---|---|---|---|---|---|
| Gold nanoparticles, target plate (AuNPET) | Pentedrone, diphenylamine, metronidazole and endogenous compound (saccharides, ionic and non-ionic glycerides, amino acids, fatty acids, sulfides, sulfoxides, phenols) in human FP, onion bulb, chicken liver | In situ on target plate (84 h reaction) | A volume of 0.5 µL of extract of liver, 1 µL of onion extract, was placed directly on AuNPET, air dried, and measured within 60–1000 | n/d | [ |
| AuNPET | Nucleosides, saccharides, amino acids, glycosides, nucleic bases | In situ | Stock solution (1 mg/mL) of each analyte was prepared, diluted, and 0.3 µL of the final solution was applied to the AuNPET and air- dried | n/d | [ |
| Gold nanoparticles | Carbohydrates, steroids, bile acids | Ready to use from manufacturer | Analytes were dissolved into 3:1 acetonitrile: water with 0.1% formic acid (FA) at a 2.0 × 10−2 M and diluted to make matrix-to-analyte ratios of 1 × 104:1, 1 × 105:1, and 1 × 106, 3 μL of each solution was spotted and dried on separate wells of a stainless steel plate | n/d | [ |
| AgNPET | Amino acids (AAs) from blood samples | In situ from silver-109 trifluoroacetate dissolved in tetrahydrofuran (THF) | Volumes of 0.5 μL of amino acid solutions diluted 10 times were placed directly on target plate and air dried, target was inserted into MS apparatus; | LOD for AAs (pg/mm2): Arg—0.9; His—0.13; Ile—0.06; Met—0.13; Ser—0.16; Phe—0.1; Tyr—2.6; Ala—64 (fg/mm2); Asp—12; Cys—41; Lys—2.3 pg/spot | [ |
| AgNPET (monoisotopic 109Ag) | AA: Trp, His, Ser, Met, Arg, Pro, Cys, Gln, Glu, Asp, Ala, Tyr, Leu, and Phe | Silver trifluoroacetate (200 mg) was dissolved in anhydrous, inhibitor-free THF (250 mL) and the solution poured into a large beaker containing a target plate. Solid 2,5-dihydroxy acid benzoic (DHB) (400 mg) was added and, following stirring, the solution was left for 24 h | Samples (0.5 μL) of the final solutions (dissolved in water) were applied to the sample plate and air-dried | Signal-to-noise (S/N) ratio: Gln, Ala, Phe, Leu, Glu, Tyr, Cys, Ser higher than 200; Arg—10. | [ |
| Silver nanoparticles | Different lipid classes from mouse and rat tissues, including brain, kidney, liver, and testis | Silver layers were deposited on top of the tissue sections using a sputter coater | All tissues were sectioned at 14 μm thickness using a cryostat and thaw-mounted on ITO coated slides; tissues were dried in desiccators prior to the silver deposition | n/d | [ |
| AgNPs | triglycerides (TAG, C8−C16) and phosphatidylcholines (PC): 1,2-dimyristoyl-sn-glycero-3-PC (DMPC), 1,2-dipalmitoyl-sn-glycero-3-PC (DPPC), and 1-palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC) | Porous AgNPs-impregnated thin films were prepared by the sol-gel method | A mixture of analytes was spotted directly to the surface and analyzed | n/d | [ |
| AgNPs | Tetrapyridinporphyrin (TPyP), oligomers of polyethylene glycol, peptide of oxytocin | Electroless plating of nanoparticles on porous silicon for desorption–ionization on porous silicon (DIOS) | PEG was dissolved in acetonitrile (ACN), TPyP in dichloromethane (DCM), and oxytocin in MILLIQ water, diluted and 1 µL was dropped onto the silver film of the substrate, air-dried, and chip was introduced immediately into the mass spectrometer | LODs, fmol: TPyP—1.3 Oxytocin—1.5 | [ |
| Silver colloids | Cuticular wax metabolites from | Commercial colloidal silver was sprayed to the target; the parameters for spraying were optimized; the sample was air-dried after each application | Collected flower and leaf samples from plants were stored in the ice before attaching them to sample plates; they were attached onto a stainless steel target plate of similar dimensions as a microscope glass slide using a conductive double-sided tape | n/d | [ |
| AgNPs/zinc oxide nanorods (ZnO NRs) | Amino acids, polyethylene glycol (PEG) (MW 2000), | ZnO NRs were fabricated through seed layer-assisted hydrothermal method; then ZnO NRs were modified with TPFS and decorated with evaporated Ag NPs; seed layers was formed on silicon wafers | A volume of 3 µL of analyte solution was added on substrate, then dried in air at room temperature; the substrate was mounted on a target plate using double-sided carbon tape | Arg—1.0 × 10–15 M; PEG—2000–1.0 × 10–10 M; R6G—1.0 × 10–15 M | [ |
| Zinc oxide nanoparticles | Small drug molecules (nortriptyline, amitriptyline, imipramine, promazine) in latent fingerprint | Nanoparticles were synthesized by microemulsions and dried at 110 °C overnight | The thumb was wiped across the forehead for 10 s and then pressed against the target plate or a glass slide for 10 s, leaving an impression on the surface; following deposition, NPs or the DHB organic matrix were applied to the LFP by dusting using a brush; fingerprint surface was spiked with 3 protocols | n/d; (relative standard deviations (RSDs) for [M-H]+ in %: nortriptyline—0.094; amitriptyline—0.202; imipramine—0.036; promazine—0.199 | [ |
| AuNPs | Peptide fragments from standard protein digests of bovine serum albumin, bovine catalase, and bovine lactoperoxidase | Gold thin film was deposited on indium tin oxide (ITO) -conductive glass | Protein digests were dissolved in 80% ACN and 20% citrate buffer solution (3:1 50 mM ammonium citrate/100 mM citric acid) and 0.2 µL of each digest were spotted on the hydrophilic etched gold spots | angiotensin I peptide—8 fmol | [ |
| AuNPs | Testosterone, progesterone, cortisol, ribose, glucose, maltose, 5- 5-hydroxyindolacetic acid (HIAA), tryptophan, gangliozyd (GM1), angiotensin I from urine samples | A solution of the AuNPs was prepared by the chemical reduction of metal salt precursor in a liquid solution | Urine samples were directly deposited onto the sample plate and allowed to dry in air; then, an equal volume of 13 nM Au NPs or 20 mg/mL DHB was deposited onto the first | LOD, nm: Testosterone—188; Progesterone—389.8; Cortisol—641; Ribose—1395; Glucose—393.4; Maltose—785.3; 5-HIAA—46.5; Trp—141.5; GM1—1648.4; Angiotensin I—5115.7 | [ |
| ZnO NPs | Polyethylene glycol, polystyrene and polymethylmethacrylate, oligosaccharides, lipids | ZnO was suspended to achieve 10 wt % in methanol; the suspended solution was irradiated by ultrasonic agitation for 2 h | Each 0.6 µL of the ZnO dispersed solution and analyte solutions were placed on a stainless-steel sample target (384 wells) and dried at room temperature; NaI (0.1 mM) was added to all sample solutions as cationizing agent, except for verapamil hydrochloride | Β-cyclodextrin and hexa-N-acetylchitohexaose—1 pmol | [ |
| Platinum nanoparticles | Saccharides, pigments, and drugs | Vapor deposition Pt deposition on the target imaging sample was performed by commercially available magnetron sputtering device | Pt-deposited sample was mounted onto a holder plate and fixed using electrically conductive carbon tape | n/d | [ |
| AuNPs | Endogenous chemicals in latent fingerprints (LFPs) | Vapor deposition by sputtering | To prepare sebum-rich LFPs, the donor wiped his thumb on his forehead for about 10 s, and then pressed his thumb on the desired substrates gently for about 10 s | n/d | [ |